Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MiMedx Group, Inc - Common Stock (NQ:MDXG)

6.345 +0.005 (+0.08%)
Streaming Delayed Price Updated: 10:49 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MiMedx Group, Inc - Common Stock

< Previous 1 2 3 Next >
MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities
MiMedx Group Inc (NASDAQ: MDXG) announced a strategic realignment to focus its resources on its Wound & Surgical business, driving profitability and  
Via Benzinga
MiMedx Group (NASDAQ: MDXG) Reports Q1 2023 Financial Results Showing 21.7% Sales Growth
MiMedx Group, Inc. (NASDAQ: MDXG) is engaged as a biotechnology company that is focused as a placental biologics developer to 
Via Spotlight Growth
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Recap: MiMedx Group Q4 Earnings
MiMedx Group (NASDAQ:MDXG) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •... 
Via Benzinga
BioStem Aims To Stay Ahead Of Competition Through Its Unique Processes And Versatile Offerings In Wound Healing
The human body has an amazing ability to heal itself, but the pace and extent of healing can vary dramatically from case to case, depending on the nature of the injury, site and the extent of tissue... 
Via Benzinga
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027
EQNX::TICKER_START (OTCQB:OCEL),(NASDAQ:BRTX),(NASDAQ:MDXG),(NYSE:NNVC),(NASDAQ:VCEL) EQNX::TICKER_END 
Via FinancialNewsMedia
Nikola, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning ahead of the PPI data for August. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Upgrades 
Via Benzinga
MiMedx Group: Q2 Earnings Insights
MiMedx Group (NASDAQ:MDXG) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MiMedx Group missed estimated... 
Via Benzinga
Earnings Outlook For MiMedx Group
MiMedx Group (NASDAQ:MDXG) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that MiMedx Group... 
Via Benzinga
MiMedx Group's Return on Invested Capital Insights
Benzinga Pro data, MiMedx Group (NASDAQ:MDXG) reported Q1 sales of $58.89 million. Earnings fell to a loss of $10.49 million, resulting in a 573.54% decrease from last quarter. 
Via Benzinga
Recap: MiMedx Group Q1 Earnings
MiMedx Group (NASDAQ:MDXG) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MiMedx Group missed estimated... 
Via Benzinga
Earnings Outlook For MiMedx Group
MiMedx Group (NASDAQ:MDXG) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that MiMedx Group... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 40.5... 
Via Benzinga
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. 
Via Benzinga
86 Biggest Movers From Yesterday
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million.... 
Via Benzinga
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.38% to 34,739.18 while the NASDAQ fell 0.27% to 15,074.10. The S&P also fell, dropping 0.07% to 4,455.53. The U.S. has... 
Via Benzinga
Topics Stocks
72 Biggest Movers From Yesterday
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... 
Via Benzinga
Dow Set to Snap Skid, Eyes Best Day in a Month
The Dow Jones Industrial Index is seeing a dramatic rebound off its five-day slump, last seen up 263 points and on track for its best single-session gain since Aug. 5. 
Via Talk Markets
Topics Stocks
Why Shares of MiMedx Are Collapsing Today
The company released data for two drug programs and missed its goals on both. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Itamar Medical (NASDAQ:ITMR) shares increased by 46.58% to $30.25 during Monday's regular session. Trading volume for Itamar Medical's stock is 2.6 million... 
Via Benzinga
Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet
Midway through trading Monday, the Dow traded up 0.80% to 34,885.46 while the NASDAQ fell 0.10% to 15,100.02. The S&P also rose, gaining 0.23% to 4,468.75. The U.S. has the... 
Via Benzinga
Topics Stocks
45 Stocks Moving In Monday's Mid-Day Session
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva's COVID-19 Vaccine Contract
Following the market opening Monday, the Dow traded up 0.61% to 34,817.26 while the NASDAQ fell 0.40% to 15,055.69. The S&P also rose, gaining 0.05% to 4,460.84. The U.S. has... 
Via Benzinga
Topics Stocks
Why MiMedx Shares Are Diving Today
MiMedx Group Inc (NASDAQ: MDXG) is trading significantly lower Monday after the company announced top-line results from two late-stage musculoskeletal clinical trials. ... 
Via Benzinga
Mimedx Stock Plunges After Disappointing Data From Musculoskeletal Trials
MiMedx Group Inc (NASDAQ: MDXG) stock dropped after announcing top-line results from two musculoskeletal trials of micronized dehydrated Human Amnion Chorion... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.